989425

Amgen, Inc. — FEI 2026154

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 1, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Thousand Oaks, CA (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)